Particularly, hepatoprotective and antifibrogenic properties have been recently suggested for CB2 receptors both through experimental murine models of liver injury and association study between a common functional variant of CB2, Q63R, with liver enzymes in a cohort of 438 Italian obese children with steatosis at ultrasound imaging [15]–[17]. This evidence concerns the gene CNR2 and steatosis.